Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: No influence of the presence of anti-citrullinated peptide antibodies

Clinical and Experimental Rheumatology

Volumn 25, Issue 4, 2007, Pages 523-528

  Faragó, Bernadett ^a   Talián, Gábor C ^a   Maász, Anita ^a   Magyari, Lili ^a   Horvatovich, Katalin ^a   Kovács, Beáta ^a   Cserép, Veronika ^a   Kisfali, Péter ^a   Kiss, Csaba G ^a   Czirjḱ, László ^a   Melegh, Béla ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Anti CCP; Caucasian; Haplotype; PADI4; RF; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; PROTEIN ARGININE DEIMINASE; PROTEIN ARGININE DEIMINASE 4; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HUNGARY; HYDROLASES; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PREVALENCE; RHEUMATOID FACTOR;

EID: 34748855536     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. JARVINEN P, AHO K: Twin studies in rheumatic diseases. Semin Arthritis Rheum 1994; 24: 19-28.
2. KISS CG, LOVEI C, SUTO G et al.: Prevalence of rheumatoid arthritis in the South-Trans-danubian region of Hungary based on a representative survey of 10,000 inhabitants. J Rheumatol 2005; 32: 1688-90.
3. AHO K, KOSKENVUO M, TUOMINEN J, KAPRIO J: Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986; 13: 899-902.
4. BARTON A, BOWES J, EYRE S, SYMMONS D, WORTHINGTON J, SILMAN A: Investigation of polymorphisms in the PAD14 gene in determining severity of inflammatory polyarthritis. Ann Rheum Dis 2005; 64: 1311-5.
5. CORNELIS F, FAURE S, MARTINEZ M et al.: New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998; 95: 10746-50.
6. CAPONI L, PETIT-TEIXEIRA E, SEBBAG M et al.: A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis 2005; 64: 587-93.
7. DEIGHTON CM, WALKER DJ, GRIFFITHS ID, ROBERTS DF: The contribution of HLA to rheumatoid arthritis. Clin Genet 1989; 36: 178-82.
8. DIEUDE P, CORNELIS F: Genetic basis of rheumatoid arthritis. Joint Bone Spine 2005; 72: 520-6.
9. HARNEY SM, MEISEL C, SIMS AM, WOON PY, WORDSWORTH BP, BROWN MA: Genetic and genomic studies of PADI4 in rheumatoid arthritis. Rheumatology (Oxford) 2005; 44: 869-72.
10. IKARI K, KUWAHARA M, NAKAMURA T et al.: Association between PAD14 and rheumatoid arthritis: A replication study. Arthritis Rheum 2005; 52: 3054-7.
11. SELDIN MF, AMOS CI, WARD R, GREGERSEN PK: The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999; 42: 1071-9.
12. SHIOZAWA S, HAYASHI S, TSUKAMOTO Y et al.: Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 1998; 10: 1891-5.
13. SUZUKI A, YAMADA R, CHANG X et al.: Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003; 34: 395-402.
14. WEYAND CM, GORONZY JJ: Association of MHC and rheumatoid arthritis. HLA polymorphisms; in phenotypic variants of rheumatoid arthritis. Arthritis Res 2000; 2: 212-6.
15. YAMADA R, SUZUKI A, CHANG X, YAMAMOTO K: Peptidylarginine deiminase type 4: Identification of a rheumatoid arthritis-susceptible gene. Trends Mol Med 2003; 9: 503-8.
16. VAN VENROOIJ WJ, PRUIJN GJ: Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2000; 2: 249-51.
17. YAMADA R, SUZUKI A, CHANG X, YAMAMOTO K: Citrullinated proteins in rheumatoid arthritis. Front Biosci 2005; 10: 54-64.
18. YAMAMOTO K, YAMADA R: Genome-wide single nucleotide polymorphism analyses of rheumatoid arthritis. J Autoimmun 2005; 25 (Suppl.): 12-5.
19. CANTAERT T, COUCKE P, DE RYCKE L, VEYS EM, DE KEYSER F, BAETEN D: Functional haplotypes of PADI4: Relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anti-citrullinated protein antibodies. Ann Rheum Dis 2005; 64: 1316-20.
20. MORI M, YAMADA R, KOBAYASHI K, KAWAIDA R, YAMAMOTO K: Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 2005; 50: 264-6.
21. ROTH EB, STENBERG P, BOOK C, SJOBERG K: Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis - new pathways to epitope spreading. Clin Exp Rheumatol 2006; 24: 12-8.
22. MARTINEZ A, VALDIVIA A, PASCUAL-SALCEDO D et al.: PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology (Oxford) 2005; 44: 1263-6.
23. KANG CP, LEE HS, JU H, CHO H, KANG C, BAE SC: A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 2006; 54: 90-6.
24. BARTON A, BOWES J, EYRE S et al.: A functional haplotype of the PAD14 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 2004; 50: 1117-21.
25. HOPPE B, HAUPLT, GRUBER R et al.: Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: A case-control study. Arthritis Res Ther 2006; 8: R34.
26. VAN BOEKEL MA, VOSSENAAR ER, VAN DEN HOOGEN FH, VAN VENROOIJ WJ: Auto-antibody systems in rheSmatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002; 4: 87-93.
27. GARCIA-BERROCAL B, GONZALEZ C, PEREZ M et al.: Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients. Clin Chim Acta 2005; 354: 123-30.
28. SEMINO O, PASSARINO G, QUINTANA-MURCI L et al.: MtDNA and Y chromosome polymorphisms in Hungary: Inferences from the palaeolithic, neolithic and Uralic influences on the modern Hungarian gene pool. Eur J Hum Genet 2000; 8: 339-46.
29. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.